Pharmacology Flashcards
(42 cards)
PPIs - Mechanism
Covalently bind to and irreversibly inactivate H/K/ATPase
Results in a 80-95% reduction in daily acid production; may take 2-5 days to reach steady state inhibition
PPIs - Pharmacokinetics
Systemic absorption is improved by administration as enteric-coated capsules or with sodium bicarbonate
Administered on empty stomach 1 hour before meals so that peak plasma concentration occurs with maximal proton pump secretion
Metabolized by CYP450 in the liver; dosage reduction necessary in liver disease
PPIs - Clinical Uses
GERD - First line therapy
Peptic Ulcer Disease - H.pylori and NSAID-induced; for symptomatic relief and ulcer healing
Prevention of stress gastritis
Zollinger-Ellison syndrome
PPIs - Adverse Effects
Headache, abdominal pain, nausea, constipation/diarrhea
Hypergastrinemia resulting from chronic PPI use may cause rebound gastric acidity upon discontinuation
Omeprazole - DDIs
Inhibits conversion of Clopidogrel to active form leading to a hypercoagulable state
H2 receptor antagonists - Agents
Ranitidine
Cimetidine
Famotidine
Nizatidine
H2 receptor antagaonists - Mechanism
Reversible, competitive block at parietal H2 receptors on the basolateral membrane; normally, histamine binding to H2 receptors activates Gs, increasing intracellular cAMP and leading to phosphorylation of the H/K/ATPase, which activates it
H2 receptor antagonists vs. PPIs
Somewhat less effective than PPIs but still suppress 24 hour acid secretion by 70%
Better at blocking nocturnal acid secretion (90%) than meal-stimulated acid secretion (60-80%)
H2 receptor antagonists - Pharmacokinetics
Rapidly absorbed from GI tract; some enhancement with food, decreased with antacids
No dosage adjustment necessary for liver disease; dosage reduction IS required in renal dysfunction, especially in the elderly
H2 antagonists - Clinical Uses
GERD - OTC treatment for infrequent heartburn; PPIs preferred in severe disease
PUD - Useful for suppressing nocturnal acid secretion; PPIs preferred for more severe disease
H2 antagonists - Adverse Effects
Dizziness, diarrhea, constipation, headache
Rarely CNS dysfunction / mental status changes more commonly seen with Cimetidine in the elderly
Gynecomastia, galactorrhea, decreased sperm count - with high doses of Cimetidine
Sucralfate - Mechanism
Disaccharide aluminum salt; selectively binds to necrotic ulcer tissue to form a protective barrier which prevents pepsin from hydrolyzing mucosal proteins causing further erosion/ulceration
Sucralfate - Pharmacokinetics
Activated by pH < 4 - efficacy decreased by administration with antacids; best on empty stomach 1 hour before meals
No systemic absorption; administered 2-4x/day
Misoprostol - Mechanism
Prostaglandin (PGE1) analog - inhibits cAMP formation in gastric parietal cells, decreasing H+ secretion and stimulating bicarbonate and mucous secretion
Administered orally 3-4x/day
Misoprostol - Uses and Adverse Effects
Alleviation of NSAID-induced GI ulceration
Side effects: Diarrhea, uterine cramping (contraindicated during pregnancy)
Ca2+ Antacids - Adverse Effects
Constipation
With long-term use: hypercalcemia, renal calculi, rebound acid secretion
Antacids - DDIs
Decreased absorption of: tetracycline, fluoroquinolones, digoxin, chlorpromazine
Increased excretion of aspirin due to alkalinization of urine
Reduced bioavailability of H2 antagonists and Ketoconazole due to increased gastric pH
Al3+ Antacids - Adverse Effects
Constipation
With long-term use: CNS toxicity / Encephalopathy
Mg2+ Antacids - Adverse Effects
Diarrhea
Avoid use in renal failure as Mg2+ can occur
Sodium Bicarbonate Antacids - Adverse Effects
Contraindicated for prolonged use due to systemic effects
Na overload and alkalosis can occur; contraindicated in conditions exacerbated by fluid overload (pregnancy, CHF, HTN, edema, renal failure)
General mechanism of prokinetic agents
All promotility drugs directly or indirectly increase ACh agonist activity at smooth muscle M3 receptors
Erythromycin
Pro-motility agent
Agonist at excitatory smooth muscle motilin receptors
Cisapride - Uses, mechanism, and adverse effects
Pro-motility agent
Agonist at excitatory neural 5-HT4 receptors on enteric nervous system cholinergic motor neurons; directly increases ACh release in the gut, stimulating motility
Adverse effects: QT prolongation / arrhythmia
Metoclopramide - Uses, mechanism, adverse effects
Antagonist at pre-synaptic dopamine (D2) receptors which normally inhibit release of ACh; indirectly increases ACh release in the gut
Anti-dopaminergic effect also relieves nausea and vomiting by blocking DA receptors in chemoreceptor trigger zone
Adverse effects: Somnolence, dystonia, tardive dyskinesia